Article Information
History
- July 30, 2020.
Article Versions
- Version 1 (May 2, 2020 - 20:10).
- Version 2 (May 5, 2020 - 23:00).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Bryan Frey1,
- Abdelrahman AlOkda1,
- Matthew. P. Jackson2,
- Nathan Riguet1,
- James A. Duce2 and
- Hilal A. Lashuel1,*
- 1Laboratory of Molecular and Chemical Biology of Neurodegeneration, Brain Mind Institute, Faculty of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, CH 1015
- 2ALBORADA Drug Discovery Institute, University of Cambridge, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0AH, UK
- ↵*To whom correspondence should be addressed: Hilal A. Lashuel, Brain Mind Institute, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, CH-1015, Switzerland. Phone: +41 21 69 39691; Email: hilal.lashuel{at}epfl.ch.